Results 291 to 300 of about 119,295 (311)

Targeting Oncogenic BRAF: Past, Present, and Future

Cancers, 2019
Trever G Bivona, Aubhishek Zaman
exaly  

BRAF

2008
openaire   +1 more source

Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patients

Annals of Oncology, 2015
Markus Hecht, S Semrau, R Gutzmer
exaly  

DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma

Annals of Oncology, 2014
Paul Lorigan, Christian H. Ottensmeier, M R Middleton   +2 more
exaly  

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study

British Journal of Cancer, 2009
C Dive, M Ranson, C Morris
exaly  

BRAF

2011
openaire   +1 more source

The distribution of BRAF gene fusions in solid tumors and response to targeted therapy

International Journal of Cancer, 2016
Julia A Elvin, Brooke Nakamura, Vincent A Miller   +2 more
exaly  

Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid

Cancer, 2007
Young-Sik Kim, Ju-Han Lee, Eung-Seok Lee
exaly  

Integrating multimodal management and molecular profiling in a patient with BRAF V600E–positive melanoma and brain metastases

Ca-A Cancer Journal for Clinicians
Ryan J Sullivan, Gavin P Dunn, Daniel P Cahill   +2 more
exaly  

Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations

Annals of Oncology, 2014
H Asamura, T Mizukami, K Furuta
exaly